VNRX Volitionrx Ltd

VolitionRX Ltd is a clinical-stage life sciences company. The Company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.

$2.31  +0.08 (3.59%)
As of 11/25/2022 13:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  10/11/2011
Outstanding shares:  57,296,973
Average volume:  126,275
Market cap:   $127,772,250
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy